Novo Nordisk | NVO - DEBITO





DEBITO Cambiamento Data
ANI Pharmaceuticals USD 613.76M 3.28M 2026-03
Aurora Cannabis CAD 23.86M 76.48M 2026-03
Bausch Health Companies USD 20.78B 16M 2026-06
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Canopy Growth CAD 278.71M 19.38M 2026-03
Corcept Therapeutics USD 9.64M 3.53M 2026-03
Drreddys Laboratories INR 77.34B 9.61B 2026-03
Eli Lilly USD 43.37B 867M 2026-03
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Merck USD 49.12B 222M 2026-03
Nektar Therapeutics USD 0 0 2022-06
Novartis USD 49.01B 2.02B 2026-06
Novo Nordisk DKK 118.72B 61.75B 2025-03
Novo Nordisk DKK 146.38B 27.66B 2026-03
Pacira USD 363.12M 4.53M 2026-06
Perrigo USD 3.63B 7.7M 2026-03
Phibro Animal Health USD 474.17M 730K 2024-09
Prestige Brands USD 1.05B 33.86M 2026-03
Sanofi EUR 23.58B 3.56B 2026-06
Supernus Pharmaceuticals USD 40.17M 733K 2026-06
Zoetis USD 9.24B 0 2026-03